Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. Viewhere

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSND.L Regulatory News (SND)

  • There is currently no data for SND

Regulatory Condition to Conditional Subscription

29 May 2024 07:00

RNS Number : 1680Q
Sondrel (Holdings) plc
29 May 2024
 

29 May 2024

 

Sondrel (Holdings) plc

("Sondrel", the "Company" and together with its subsidiaries the "Group")

 

Regulatory Condition to Conditional £5.6m Subscription

 

Sondrel (AIM: SND), a leading provider of ultra-complex chips for leading global technology brands, announced on 14 May 2024 that it had conditionally raised gross proceeds of £5,625,400 pursuant to a subscription by ROX Equity Partners Limited for 56,254,000 new ordinary shares in the Company at an issue price of 10 pence per new ordinary share (the "Subscription").

 

The Subscription remains conditional upon, inter alia, Sondrel independent shareholder approval at a general meeting to be held on 30 May 2024 (the "General Meeting") and approval by the UK secretary of state of ROX's proposed investment in the Company as required by the National Security and Investment Act 2021 ("NSIA Approval").

 

Sondrel announces that it has now been informed that NSIA Approval is unlikely to be received prior to the General Meeting. As such it is currently anticipated that admission of the new ordinary shares to be issued pursuant to the Subscription will take place after 31 May 2024, but prior to the agreed long stop date of 8:00 am on 13 June 2024.

 

A further announcement in connection with the status of the NSIA Approval, together with an updated admission date, will be made in due course as and when appropriate.

 

 

For further information:

 

Sondrel (Holdings) plc

Via Buchanan

David Mitchard, Interim CEO

Tel: +44 (0) 20 7466 5000

Nick Stone, Interim CFO

Cavendish Capital Markets Limited

Tel: +44 (0) 20 7220 0500

Ben Jeynes / Katy Birkin / George Lawson - Corporate Finance

Michael Johnson / Charlie Combe - Sales and ECM

Buchanan Communications

Tel: +44 (0) 20 7466 5000

Chris Lane

Stephanie Whitmore

sondrel@buchanan.uk.com

 

Jack Devoy

Abby Gilchrist

 

About Sondrel

Sondrel is a UK-based fabless semiconductor company specialising in high end, complex digital Application Specific Integrated Circuits (ASICs) and System on Chips (SOCs). It provides a full turnkey service in the design, prototyping, testing, packaging and production of ASICs and SoCs.

 

The Company is one of only a few companies capable of designing and supplying the higher-spec chips built on the most advanced semiconductor technologies, selling into a range of hyper growth end markets such as high-performance computing, automotive, artificial intelligence, VR/AR, video analytics, image processing, mobile networking and data centres. Sondrel designs have enabled products by leading technology brands including Apple (iPhone), Sony (PlayStation), Meta's (Oculus), Samsung, Google and Sony smartphones, JVC (prosumer camcorders), Tesla and Mercedes-Benz cars.

 

Sondrel is well-established, with a 20-year track record of successful delivery, supported by long standing ecosystem partnerships including Arm, TSMC and Samsung. Headquartered in the UK, Sondrel has a global presence with offices in UK, USA, China, India and Morocco.

 

For more information please visit: ir.sondrel.com.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCBRGDUGUDDGSI
Date   Source Headline
11th Mar 20107:00 amRNSAGM Trading Update
17th Feb 201011:04 amRNSPosting of Annual Report
1st Feb 20102:11 pmRNSHolding(s) in Company
1st Feb 20107:00 amRNSDirector/PDMR Shareholding
7th Dec 20097:00 amRNS2009 Final Results
2nd Nov 20097:00 amRNSTrading Update
10th Aug 20093:02 pmRNSDirectors' Shareholdings
6th Aug 200912:16 pmRNSDirectors' Shareholdings
4th Aug 20094:34 pmRNSDirectors' Share Purchases
4th Aug 20091:00 pmRNSGrant of Options
3rd Aug 20097:00 amRNSNew Financing Arrangements
30th Jun 20097:00 amRNS2009 Interim Results
30th Apr 20097:00 amRNSTrading Update
6th Apr 200912:00 pmRNSDirector/PDMR Shareholding
27th Feb 20097:00 amRNSDirectorate Change & Result of AGM
3rd Feb 20097:00 amRNSPublication of 2008 Annual Report & Notice of AGM
8th Dec 20087:00 amRNSFinal Results
24th Nov 200812:15 pmRNSChange of Adviser
15th Oct 200812:34 pmRNSTrading Update
9th Sep 200810:00 amRNSDirectors' Share Purchases
12th Jun 20087:00 amRNSInterim Results
4th Jun 20087:00 amRNSNotice of Interim Results
6th May 20087:02 amRNSIssue of Equity
7th Apr 20087:01 amRNSDirectors' Shareholdings
14th Feb 20083:25 pmRNSResult of AGM
4th Feb 20081:00 pmRNSAdditional Listing
23rd Jan 200811:23 amRNSPublication of Annual Report
6th Dec 20077:01 amRNS2007 Final Results
29th Oct 20072:19 pmRNSHolding(s) in Company
28th Sep 200711:27 amRNSTotal Voting Rights
18th Sep 200712:52 pmRNSHolding(s) in Company
17th Sep 20073:18 pmRNSAdditional Listing
17th Sep 200712:26 pmRNSDirectors' Shareholdings
14th Sep 20077:00 amRNSGBP14million acquisition
15th Aug 20075:14 pmRNSAIM Rule 26
24th May 20077:03 amRNSInterim Results
12th Feb 20077:02 amRNSAcquisition
11th Dec 200611:45 amRNSTotal Voting Rights
6th Dec 20062:13 pmRNSHolding(s) in Company
6th Dec 20067:02 amRNS2006 Final Results
29th Nov 20067:03 amRNSNotice of Final Results
25th May 20064:48 pmRNSDirector/PDMR Shareholding
24th May 20065:07 pmRNSDirector/PDMR Shareholding
23rd May 20064:56 pmRNSDirector/PDMR Shareholding
9th May 20064:32 pmRNSDirector/PDMR Shareholding
4th May 20067:02 amRNSInterim Results
23rd Feb 20067:03 amRNSAcquisition
12th Jan 20069:56 amRNSAGM Statement
21st Nov 200511:24 amRNSDirector Dealings
17th Nov 20052:25 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.